Newborn Screening Panel and Timeline - Minnesota Dept. of Health

Newborn Screening Panel and Timeline


Minnesota's Newborn Screening Panel

The newborn screening panel refers to the list of disorders that newborns are screened for shortly after birth. In Minnesota, disorders are added to this panel by the Commissioner of Health with advice and recommendations from Minnesota's Advisory Committee on Heritable and Congenital Disorders.

Screening panels may vary from state to state. The Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) provides national recommendations on which disorders should be screened for in all states to the Secretary of Health and Human Services. However, each state ultimately determines which disorders to include in its panel.

2018 Newborn Screening Disorder Panel (PDF)


Minnesota's Newborn Screening Timeline

Primary targets of newborn screening Year/date screening started

Phenylketonuria

1964

Congenital hypothyroidism

1968

Galactosemia

1974

Sickle cell disease

1988

Sickle-C disease

1988

S-βeta thalassemia

1988

Congenital adrenal hyperplasia

8/13/1992

3-Hydroxy-3-methylglutaryl-CoA lyase deficiency

1/18/2001

3-Methylcrotonyl-CoA carboxylase deficiency

1/18/2001

Argininosuccinate acidemia

1/18/2001

Beta ketothiolase deficiency

1/18/2001

Carnitine uptake defect

1/18/2001

Citrullinemia type 1

1/18/2001

Glutaric acidemia type 1

1/18/2001

Homocystinuria

1/18/2001

Isovaleric acidemia

1/18/2001

Long-chain hydroxyacyl-CoA dehydrogenase deficiency

1/18/2001

Maple syrup urine disease

1/18/2001

Medium-chain acyl-CoA dehydrogenase deficiency

1/18/2001

Methylmalonic acidemia (3 types)

1/18/2001

Multiple CoA carboxylase deficiency

1/18/2001

Propionic acidemia

1/18/2001

Trifunctional protein deficiency

1/18/2001

Tyrosinemia type 1

1/18/2001

Very long-chain acyl-CoA dehydrogenase deficiency

1/18/2001

Biotinidase deficiency

10/26/2004

Cystic fibrosis

3/1/2006

Hearing loss

5/26/2007 (date screening was mandated)

Severe combined immunodeficiency

1/7/2013

Critical congenital heart disease

8/1/2013 (date screening was mandated)

X-linked adrenoleukodystrophy

2/6/2017

Mucopolysaccharidosis type I

8/1/2017

Pompe disease

8/1/2017

Spinal muscular atrophy

3/1/2018